Overview

EVOLVE Short DAPT Study

Status:
Completed

Trial end date:
2019-07-17

Target enrollment:

Participant gender:

Summary

The EVOLVE Short DAPT Study is a prospective, multicenter, single-arm study designed to assess the safety of 3-month DAPT in subjects at high risk for bleeding undergoing PCI with a SYNERGY Stent System.

Phase:

Phase 4

Details

Lead Sponsor:

Boston Scientific Corporation

Treatments:

Chromium
Everolimus